USPTO serial 87122899
NOBELPHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 4, 2018
- Examiner
- CASE, LEIGH CAROLINE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.
Need help with NOBELPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sandra Epp Ryan
Sandra Epp Ryan HSML P.C.45 S. 7th St., Ste. 2700Minneapolis, MN 55402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for treating tympanic membrane perforation and ear canal soft tissue defect; pharmaceutical preparations for treating skin disorders; vaccines; vaccines for treating malaria | ACTIVE | — |
| 010 | [ Medical apparatus and instruments for treating spasmodic dysphonia; medical apparatus and instruments for type 2 thyroplasty ] | SECTION 8 - CANCELLED | — |
| 044 | Providing medical information; providing pharmaceutical information; medical and pharmaceutical consultation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nobelpharma Co., Ltd.
- Other trademarks owned by Nobelpharma Co., Ltd.
- Other trademarks owned by Nobelpharma Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named NOBELPHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 27, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Mar 27, 2025 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Mar 27, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 21, 2024 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Sep 4, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 4, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 19, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 19, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 30, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 4, 2018 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Mar 30, 2018 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Mar 28, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2017 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 29, 2017 | ALIE | ASSIGNED TO LIE | — |
| May 22, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 22, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 22, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 11, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 11, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 4, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2016 | NWAP | NEW APPLICATION ENTERED | — |